Palvella Therapeutics, Inc. (PVLA)
116.11
+0.61
(+0.53%)
USD |
NASDAQ |
May 21, 16:00
116.11
0.00 (0.00%)
After-Hours: 19:59
Palvella Therapeutics Shareholders Equity (Quarterly) : 232.31M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Incyte Corp. | 5.623B |
| Novavax, Inc. | -144.76M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Vanda Pharmaceuticals, Inc. | 280.76M |
| SELLAS Life Sciences Group, Inc. | 107.41M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 263.76M |
| Total Liabilities (Quarterly) | 31.45M |
| Current Ratio | 28.88 |